Additional file 1: of Towards a better understanding of preimplantation genetic screening for aneuploidy: insights from a virtual trial for women under the age of 40 when transferring embryos one at a time

Table S1. Dataset - Not tested. Table S2. Dataset - PGS1 (exclusion). Table S3. Dataset - PGS2 (ranking). Table S4. Dataset - PGS3 (ideal). Table S5. Population characteristics and diagnostic accuracy measures stratified for maternal age. Table S6. Effect of testing summary. Table S7. Logistic regression - PGS1. Table S8. Logistic regression - PGS2. Table S9. Logistic regression - PGS3. Table S10. Effect of testing - first transfer attempt. Table S11. Costing summary. Table S12. Cost-effectiveness analysis - PGS1 vs not testing - PGS £2,965. Table S13. Cost-effectiveness analysis - PGS1 vs not testing - PGS £1,195 (overall cost parity). Table S14. Cost-effective analysis - PGS2 vs not testing - PGS £2,965. Table S15. Cost-effective analysis - PGS2 vs not testing - PGS £598 (overall cost parity). Table S16. Cost-effective analysis - PGS3 vs not testing - PGS £2,965. Table S17. Cost-effective analysis - PGS3 vs not testing - PGS £2,496 (overall cost parity). Table S18. Cost-effectiveness analysis - PGS1 vs not testing - PGS £2,965, 2 or more embryos. Table S19. HFEA UK data collection for 16 clinics with PGS activity the period July 2011 to June 2014. (XLSX 2.77 mb)